Skip to content
Home/Companies/Biotech/baCta
baCta

baCta

Biotech·France·Active·New
Entry
2026
Hold
New
Status
Active

Who owns baCta?

baCta is a French Biotech company, currently owned by Daphni since 2026 and OVNI Capital.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Daphni
Most recent investor
Daphni
Daphni Blue · 2025 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotech
Websitebacta.bio

Ownership history

2 ownership periods

Active
Co-held by OVNI Capital and Daphni since 2024.
OVNI Capital
OVNI CapitalActive
2024 · present(2yr) · OVNI Ventures I · 2022 · VC
Daphni
DaphniActive
2026 · present(<1yr) · Daphni Blue · 2025 · VC

More from Daphni Blue

Other portfolio companies in the same fund.

AMI Labs
Active
AI/MLFrance· 2026
Astral Systems
Active
ClimateTechUK· 2026
Certo
Active
AI/MLFrance· 2026
Generare
Active
BiotechFrance· 2026
GraphTx
Active
BiotechFrance· 2026
TerraSpark
Active
ClimateTechFrance· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns baCta?

baCta is currently owned by Daphni and OVNI Capital, through Daphni Blue, since 2026.

When did Daphni and 1 other acquire baCta?

Daphni and 1 other acquired baCta in 2026.

Who has owned baCta over time?

baCta has been through 2 private-equity ownership periods: OVNI Capital · via OVNI Ventures I · since 2024; Daphni · via Daphni Blue · since 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue